Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure an Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A(1) Adenosine ReceptorAntagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function)
2011-01-01 Voors, Aa; Dittrich, Hc; Massie, Bm; Delucca, P; Mansoor, Ga; Metra, Marco; Cotter, G; Weatherley, Bd; Ponikowski, P; Teerlink, Jr; Cleland, Jg; O'Connor, Cm; Givertz, M. M.
Circulating plasma concentrations of angiotensin-converting enzyme 2 inmen and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors
2020-01-01 Sama, I. E.; Ravera, A.; Santema, B. T.; Van Goor, H.; Ter Maaten, J. M.; Cleland, J. G. F.; Rienstra, M.; Friedrich, A. W.; Samani, N. J.; Ng, L. L.; Dickstein, K.; Lang, C. C.; Filippatos, G.; Anker, S. D.; Ponikowski, P.; Metra, M.; Van Veldhuisen, D. J.; Voors, A. A.
Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure
2017-01-01 Voors, Adriaan A.; Ouwerkerk, Wouter; Zannad, Faiez; Van Veldhuisen, Dirk J.; Samani, Nilesh J.; Ponikowski, Piotr; Ng, Leong L.; Metra, Marco; Ter Maaten, Jozine M.; Lang, Chim C.; Hillege, Hans L.; Van Der Harst, Pim; Filippatos, Gerasimos; Dickstein, Kenneth; Cleland, John G.; Anker, Stefan D.; Zwinderman, Aeilko H.
Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial
2016-01-01 Demissei, Biniyam G; Postmus, Douwe; Liu, Licette C Y; Cleland, John G; O'Connor, Christopher M; Metra, Marco; Ponikowski, Piotr; Teerlink, John R; Cotter, Gad; Davison, Beth A; Edwards, Christopher; Givertz, Michael M; Bloomfield, Daniel M; Dittrich, Howard C; Voors, Adriaan A; Hillege, Hans L
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF
2020-01-01 Teerlink, John R; Diaz, Rafael; Felker, G Michael; Mcmurray, John J V; Metra, Marco; Solomon, Scott D; Legg, Jason C; Büchele, Gustavo; Varin, Claire; Kurtz, Christopher E; Malik, Fady I; Honarpour, Narimon
November 2020 at a glance: focus on comorbidities and medical treatment
2020-01-01 Tomasoni, Daniela; Adamo, Marianna; Metra, Marco
Interaction between electrolytes and the neurohumoral system. The clinico-prognostic implications of hyponatremia, hypopotassemia and hypomagnesemia in congestive heart failure]
1993-01-01 Dei Cas, Livio; Metra, Marco; Nodari, Savina; Leier, Cv; Visioli, Odoardo
Engineered Human Physiomimetic Model Integrating Microphysiological Systems of the Gut, Liver and Brain for studies of Neurodegenerative Diseases
2021-01-01 Trapecar, M; Wogram, E; Svoboda, D; Communal, C; Omer, A; Lungjangwa, T; Sphabmixay, P; Velazquez, J; Schneider, K; Wright, Cw; Mildrum, S; Hendricks, A; Levine, S; Muffat, J; Lee, Mj; Lauffenburger, Da; Trumper, D; Jaenisch, R; Griffith, Lg.
Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study
2010-01-01 Metra, Marco; Cleland, Jg; Weatherley, Bd; Dittrich, Hc; Givertz, Mm; Massie, Bm; O'Connor, Cm; Ponikowski, P; Teerlink, Jr; Voors, Aa; Cotter, G.
March 2017 at a glance: pathophysiology, imaging, biomarkers and devices
2017-01-01 Metra, Marco
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features
2021-01-01 De Francesco, Maria Antonia; Poiesi, Claudio; Gargiulo, Franco; Bonfanti, Carlo; Pollara, Patrizia; Fiorentini, Simona; Caccuri, Francesca; Carta, Valentina; Mangeri, Lucia; Pellizzeri, Simone; Rizzoni, Damiano; Malerba, Paolo; Salvetti, Massimo; Muiesan, Maria Lorenza; Alberici, Federico; Scolari, Francesco; Pilotto, Andrea; Padovani, Alessandro; Bezzi, Michela; Chiappini, Raffaella; Ricci, Chiara; Castellano, Maurizio; Berlendis, Marialma; Savio, Giulia; Montani, Giovanni; Ronconi, Maurizio; Bove, Sergio; Focà, Emanuele; Tomasoni, Lina; Castelli, Francesco; Rossini, Angelo; Inciardi, Riccardo; Metra, Marco; Caruso, Arnaldo
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study
2022-01-01 Massussi, Mauro; Adamo, Marianna; Rosato, Stefano; Seccareccia, Fulvia; Barbanti, Marco; Biancari, Fausto; Tarantini, Giuseppe; Immè, Sebastiano; Vignali, Luigi; Badoni, Gabriella; Ussia, Gian Paolo; Costa, Giuliano; Baiocchi, Massimo; Metra, Marco; Baglio, Giovanni; D'Errigo, Paola
Task force on: 'Early markers of atherosclerosis: Influence of age and sex'
2013-01-01 Ciccone, M. M.; Bilianou, E.; Balbarini, A.; Gesualdo, M; Ghiadoni, L.; Metra, Marco; Palmiero, P; Pedrinelli, R.; Salvetti, Massimo; Scicchitano, P.; Zito, A.; Novo, S.; Mattioli, A. V.
Acute heart failure: The heart failure patient's journey-the vulnerable phase: Bibliography of one hundred key papers
2015-01-01 Metra, Marco; Lombardi, Carlo Mario; Carubelli, Valentina
A hydrosilver gel for plaque control in adults affected by chronic periodontitis: Effects on the 'red complex' bacterial load. A prospective longitudinal pilot study using polymerase chain reaction analysis
2019-01-01 Lauritano, D; Nota, A; Martinelli, M; Severino, M; Romano, M; Rossi, D; Caruso, S.
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study
2019-01-01 Santema, B. T.; Ouwerkerk, W.; Tromp, J.; Sama, I. E.; Ravera, A.; Regitz-Zagrosek, V.; Hillege, H.; Samani, N. J.; Zannad, F.; Dickstein, K.; Lang, C. C.; Cleland, J. G.; Ter Maaten, J. M.; Metra, M.; Anker, S. D.; Van Der Harst, P.; Ng, L. L.; Van Der Meer, P.; Van Veldhuisen, D. J.; Meyer, S.; Lam, C. S. P.; Richards, A. M.; Lam, C. S. P.; Anand, I.; Hung, C. -L.; Ling, L. H.; Liew, H. B.; Narasimhan, C.; Ngarmukos, T.; Park, S. W.; Reyes, E.; Siswanto, B. B.; Shimizu, W.; Zhang, S.; Voors, A. A.
Roadmap for the management of heart failure patients during the vulnerable phase after heart failure hospitalizations: how to implement excellence in clinical practice
2022-01-01 Rosano, Giuseppe M C; Vitale, Cristiana; Adamo, Marianna; Metra, Marco
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)
2015-01-01 Felker, G Michael; Butler, Javed; Collins, Sean P; Cotter, Gad; Davison, Beth A; Ezekowitz, Justin A; Filippatos, Gerasimos; Levy, Phillip D; Metra, Marco; Ponikowski, Piotr; Soergel, David G; Teerlink, John R; Violin, Jonathan D; Voors, Adriaan A; Pang, Peter S
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion?
2016-01-01 Adamo, Marianna; Chiari, Ermanna; Curello, Salvatore; Maiandi, Cristian; Chizzola, Giuliano; Fiorina, Claudia; Frontini, Mario; Cuminetti, Giovanni; Pezzotti, Elena; Rovetta, Riccardo; Lombardi, Carlo Mario; Manzato, Aldo; Metra, Marco; Ettori, Federica
Acute heart failure
2015-01-01 Metra, Marco; Lombardi, Carlo Mario; Carubelli, Valentina
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure an Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A(1) Adenosine ReceptorAntagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function) | 1-gen-2011 | Voors, Aa; Dittrich, Hc; Massie, Bm; Delucca, P; Mansoor, Ga; Metra, Marco; Cotter, G; Weatherley, Bd; Ponikowski, P; Teerlink, Jr; Cleland, Jg; O'Connor, Cm; Givertz, M. M. | |
| Circulating plasma concentrations of angiotensin-converting enzyme 2 inmen and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors | 1-gen-2020 | Sama, I. E.; Ravera, A.; Santema, B. T.; Van Goor, H.; Ter Maaten, J. M.; Cleland, J. G. F.; Rienstra, M.; Friedrich, A. W.; Samani, N. J.; Ng, L. L.; Dickstein, K.; Lang, C. C.; Filippatos, G.; Anker, S. D.; Ponikowski, P.; Metra, M.; Van Veldhuisen, D. J.; Voors, A. A. | |
| Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure | 1-gen-2017 | Voors, Adriaan A.; Ouwerkerk, Wouter; Zannad, Faiez; Van Veldhuisen, Dirk J.; Samani, Nilesh J.; Ponikowski, Piotr; Ng, Leong L.; Metra, Marco; Ter Maaten, Jozine M.; Lang, Chim C.; Hillege, Hans L.; Van Der Harst, Pim; Filippatos, Gerasimos; Dickstein, Kenneth; Cleland, John G.; Anker, Stefan D.; Zwinderman, Aeilko H. | |
| Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial | 1-gen-2016 | Demissei, Biniyam G; Postmus, Douwe; Liu, Licette C Y; Cleland, John G; O'Connor, Christopher M; Metra, Marco; Ponikowski, Piotr; Teerlink, John R; Cotter, Gad; Davison, Beth A; Edwards, Christopher; Givertz, Michael M; Bloomfield, Daniel M; Dittrich, Howard C; Voors, Adriaan A; Hillege, Hans L | |
| Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF | 1-gen-2020 | Teerlink, John R; Diaz, Rafael; Felker, G Michael; Mcmurray, John J V; Metra, Marco; Solomon, Scott D; Legg, Jason C; Büchele, Gustavo; Varin, Claire; Kurtz, Christopher E; Malik, Fady I; Honarpour, Narimon | |
| November 2020 at a glance: focus on comorbidities and medical treatment | 1-gen-2020 | Tomasoni, Daniela; Adamo, Marianna; Metra, Marco | |
| Interaction between electrolytes and the neurohumoral system. The clinico-prognostic implications of hyponatremia, hypopotassemia and hypomagnesemia in congestive heart failure] | 1-gen-1993 | Dei Cas, Livio; Metra, Marco; Nodari, Savina; Leier, Cv; Visioli, Odoardo | |
| Engineered Human Physiomimetic Model Integrating Microphysiological Systems of the Gut, Liver and Brain for studies of Neurodegenerative Diseases | 1-gen-2021 | Trapecar, M; Wogram, E; Svoboda, D; Communal, C; Omer, A; Lungjangwa, T; Sphabmixay, P; Velazquez, J; Schneider, K; Wright, Cw; Mildrum, S; Hendricks, A; Levine, S; Muffat, J; Lee, Mj; Lauffenburger, Da; Trumper, D; Jaenisch, R; Griffith, Lg. | |
| Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study | 1-gen-2010 | Metra, Marco; Cleland, Jg; Weatherley, Bd; Dittrich, Hc; Givertz, Mm; Massie, Bm; O'Connor, Cm; Ponikowski, P; Teerlink, Jr; Voors, Aa; Cotter, G. | |
| March 2017 at a glance: pathophysiology, imaging, biomarkers and devices | 1-gen-2017 | Metra, Marco | |
| Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features | 1-gen-2021 | De Francesco, Maria Antonia; Poiesi, Claudio; Gargiulo, Franco; Bonfanti, Carlo; Pollara, Patrizia; Fiorentini, Simona; Caccuri, Francesca; Carta, Valentina; Mangeri, Lucia; Pellizzeri, Simone; Rizzoni, Damiano; Malerba, Paolo; Salvetti, Massimo; Muiesan, Maria Lorenza; Alberici, Federico; Scolari, Francesco; Pilotto, Andrea; Padovani, Alessandro; Bezzi, Michela; Chiappini, Raffaella; Ricci, Chiara; Castellano, Maurizio; Berlendis, Marialma; Savio, Giulia; Montani, Giovanni; Ronconi, Maurizio; Bove, Sergio; Focà, Emanuele; Tomasoni, Lina; Castelli, Francesco; Rossini, Angelo; Inciardi, Riccardo; Metra, Marco; Caruso, Arnaldo | |
| Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study | 1-gen-2022 | Massussi, Mauro; Adamo, Marianna; Rosato, Stefano; Seccareccia, Fulvia; Barbanti, Marco; Biancari, Fausto; Tarantini, Giuseppe; Immè, Sebastiano; Vignali, Luigi; Badoni, Gabriella; Ussia, Gian Paolo; Costa, Giuliano; Baiocchi, Massimo; Metra, Marco; Baglio, Giovanni; D'Errigo, Paola | |
| Task force on: 'Early markers of atherosclerosis: Influence of age and sex' | 1-gen-2013 | Ciccone, M. M.; Bilianou, E.; Balbarini, A.; Gesualdo, M; Ghiadoni, L.; Metra, Marco; Palmiero, P; Pedrinelli, R.; Salvetti, Massimo; Scicchitano, P.; Zito, A.; Novo, S.; Mattioli, A. V. | |
| Acute heart failure: The heart failure patient's journey-the vulnerable phase: Bibliography of one hundred key papers | 1-gen-2015 | Metra, Marco; Lombardi, Carlo Mario; Carubelli, Valentina | |
| A hydrosilver gel for plaque control in adults affected by chronic periodontitis: Effects on the 'red complex' bacterial load. A prospective longitudinal pilot study using polymerase chain reaction analysis | 1-gen-2019 | Lauritano, D; Nota, A; Martinelli, M; Severino, M; Romano, M; Rossi, D; Caruso, S. | |
| Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study | 1-gen-2019 | Santema, B. T.; Ouwerkerk, W.; Tromp, J.; Sama, I. E.; Ravera, A.; Regitz-Zagrosek, V.; Hillege, H.; Samani, N. J.; Zannad, F.; Dickstein, K.; Lang, C. C.; Cleland, J. G.; Ter Maaten, J. M.; Metra, M.; Anker, S. D.; Van Der Harst, P.; Ng, L. L.; Van Der Meer, P.; Van Veldhuisen, D. J.; Meyer, S.; Lam, C. S. P.; Richards, A. M.; Lam, C. S. P.; Anand, I.; Hung, C. -L.; Ling, L. H.; Liew, H. B.; Narasimhan, C.; Ngarmukos, T.; Park, S. W.; Reyes, E.; Siswanto, B. B.; Shimizu, W.; Zhang, S.; Voors, A. A. | |
| Roadmap for the management of heart failure patients during the vulnerable phase after heart failure hospitalizations: how to implement excellence in clinical practice | 1-gen-2022 | Rosano, Giuseppe M C; Vitale, Cristiana; Adamo, Marianna; Metra, Marco | |
| Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure) | 1-gen-2015 | Felker, G Michael; Butler, Javed; Collins, Sean P; Cotter, Gad; Davison, Beth A; Ezekowitz, Justin A; Filippatos, Gerasimos; Levy, Phillip D; Metra, Marco; Ponikowski, Piotr; Soergel, David G; Teerlink, John R; Violin, Jonathan D; Voors, Adriaan A; Pang, Peter S | |
| Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? | 1-gen-2016 | Adamo, Marianna; Chiari, Ermanna; Curello, Salvatore; Maiandi, Cristian; Chizzola, Giuliano; Fiorina, Claudia; Frontini, Mario; Cuminetti, Giovanni; Pezzotti, Elena; Rovetta, Riccardo; Lombardi, Carlo Mario; Manzato, Aldo; Metra, Marco; Ettori, Federica | |
| Acute heart failure | 1-gen-2015 | Metra, Marco; Lombardi, Carlo Mario; Carubelli, Valentina |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista38896
Data di pubblicazione
- In corso di stampa10
- 2020 - 202711075
- 2010 - 201915891
- 2000 - 20097438
- 1990 - 19993474
- 1980 - 1989930
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.775
- Elsevier B.V.749
- John Wiley and Sons Inc493
- Springer Science and Business Med...489
- Oxford University Press456
- Lippincott Williams and Wilkins406
- Springer350
- MDPI348
- Elsevier Ltd320
- Springer Nature256
Rivista
- EUROPEAN UROLOGY527
- BLOOD373
- PLOS ONE309
- EUROPEAN JOURNAL OF HEART FAILURE273
- JOURNAL OF NEUROLOGY273
- NEUROLOGY267
- DIGESTIVE AND LIVER DISEASE246
- EUROPEAN HEART JOURNAL222
- MULTIPLE SCLEROSIS212
- SCIENTIFIC REPORTS209
Keyword
- Humans3554
- Male2081
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- Retrospective Studies628
- COVID-19624
- Treatment Outcome603
- Prognosis475
Lingua
- eng28310
- ita1931
- fre64
- und55
- spa34
- ger25
- por12
- rus6
- grc3
- pol3
Accesso al fulltext
- no fulltext33709
- open3003
- reserved2090
- partially open82
- embargoed11
- mixed1